Speakers

Super Early Bird — Live Now
00
Days
:
00
Hours
:
00
Mins
:
00
Secs
Offer Ended
🔥 Limited tickets — price rises 30 April

The first full Agential Cannabis program launches in 2026, with our speaker lineup to be unveiled soon. Expect senior executives, regulators, and innovators from across the cannabis value chain — bringing global insights with a special focus on APAC market opportunities.

Tewan Thaneerat

Deputy Director-General
Department for Development of Thai Traditional and Alternative Medicine, The Ministry of Public Health
Thailand’s medicinal cannabis laws and regulations; Latest updates; Plans for future policies

Maythasith Konkarn

Director of Academic Group
Office of Agricultural Regulation, The Department of Agriculture (DOA)
Thailand’s Cultivation, Import, and Export of Medicinal Cannabis

Sita Schubert

General Secretary
European Medicinal Cannabis Association (EUMCA)
APAC Market Opportunities; Regulatory Challenges; GMP Cannabis

Ben Nikaj

Senior Crop Advisor
Grodan
AI-powered harvest forecasting; Rootzone data-driven precision growing; Optimizing efficiencies in indoor/GH cannabis 

Paul Long

CEO
Little Green Pharma
one of the most recognisable medical cannabis brands in Europe and Australia; APAC Cannabis Market Landscape: Capitalising on Early Opportunities

Bryan Ebstyne

CEO
Austranna
an automated large-scale medicinal cannabis farm in Australia: AI, automation and robotics; APAC cannabis market landscape; Good Manufacturing Practice (GMP) in CEA

Rehan Mehta

CEO
Thai Stick
APAC Market Opportunities; The High-Bar of GMP Medicinal Cannabis; Adapting to Local Growing Conditions

Menno Keppel

Founder & CEO 
Agri Solutions Asia
Climate-adapted greenhouse technology for Southeast Asia; Data-driven precision cannabis growing for local conditions 

Tommy Huppert

Founder | Director
Cannatrek
One of Australia’s first fully licensed medicinal cannabis producers. APAC Cannabis Market Landscape: Capitalising on Early Opportunities

Jesus Diaz

Senior Cultivation & Post-Harvest Specialist 
Austranna
Selection Techniques for Genetic Cultivars; Data-Driven Yield Optimisation

Chase Martin

Founder
Umami Seed Co 
Breeding; Genetics; High-Tech Indoor Cultivation; Data Analytics

Natcha Klahan

Chief Operating Officer
World Pharma Solutions
Medicinal Cannabis Cultivation in Thailand; Operational Leadership; Business Development; Sustainable Growth

Ben Niehaus

CTO
SpexAI
a start-up in Germany using cutting-edge imaging technology for Cannabis growth insights: Computer vision; Plant selection and breeding; AI-driven efficiency

Michael Abdo

Commercial Unit Leader – Microbiology, Infectious Diseases, Public Health Surveillance, Agrigenomics (AMEA)
Illumina
Genomics in One Health; microbiology; infectious diseases; agrigenomics; technology adoption; next-gen sequencing; AI in agriculture.

Tyson Cramer

Former VP & Chief Cultivator
Aurora Cannabis
Founder & CEO
Peak Profit Yields 
From Humboldt to global standardisation: GMP-certified production; Third-party supply management; Continuous improvement; Yield optimisation; Hydrocarbon extraction

Dedi Meiri

Associate Professor Technion Israel Institute of Technology
Cannabis phytocompounds and the entourage effect; Matching strains to patients; Precision cannabinoid medicine.

Matt Cantelo

CEO & Founder
Australian Natural Therapeutics Group (ANTG)
Exclusive Special — An Untold Story, TBA Soon!

Rehan Mehta

CEO
Thai Stick
APAC Market Opportunities; The High-Bar of GMP Medicinal Cannabis; Adapting to Local Growing Conditions

Sita Schubert

General Secretary
European Medicinal Cannabis Association (EUMCA)
APAC Market Opportunities; Regulatory Challenges; GMP Cannabis

Bryan Ebstyne

CEO
Austranna
An automated large-scale medicinal cannabis farm in Australia: AI, automation and robotics; APAC cannabis market landscape; Good Manufacturing Practice (GMP) in CEA

Paul Furfaro

President, Global Medical Cannabis Division
Village Farms International
From grower to global sourcer: CEA cultivation at scale; Evolving business models; Government regulatory leadership; Shaping cannabis trade policy from Canada to APAC

Nicholas Lintzeris

Conjoint Professor | Chair, SESLHD Collaborative Research Committee
Drug & Alcohol Services, SESLHD & University of Sydney
A leading clinician-researcher in in addiction medicine: advancing the evidence for medical cannabis, research design beyond RCTs, patient-safe regulation, and clinical integration

Chase Martin

Founder
Umami Seed Co 
Global cannabis genetics company building high-performance cultivars for commercial production, combining advanced breeding with data-driven cultivation, automation and AI.

Benjamin Selma​​​

Director of Cultivation
Hollandse Hoogtes
Large-scale cannabis cultivation in the Netherlands; cultivation leadership and team development; science-led production within the Dutch regulated supply-chain framework

Aphichai Techanitisawad

CEO
Grasshopper Collective
Thailand-based medical cannabis cultivation; genetics R&D; energy-efficient production; domestic and export supply

Ralph Risch

CEO
Phylos Bioscience
Cannabis genetics and breeding innovation in global markets; data-driven and marker-assisted breeding; genetic predictability for scalable production, regulatory compliance, and long-term industry resilience.

Tommy Huppert

Founder | Director
Cannatrek
One of Australia’s first fully licensed medicinal cannabis producers. APAC Cannabis Market Landscape: Capitalising on Early Opportunities

Sandro Bombardieri

Founder
HY-GEN
Heavy metal contamination in cultivation; Quality considerations across nutrients and inputs; Supporting compliant medicinal cannabis production

Max Edgley

Head of Cultivation
Tasmanian Botanics
Scaling Commercial Cannabis Operations; High-Tech Greenhouse Production; Smart Infrastructure & Automation; Data-Driven Cultivation Strategy

Varavij Kambhu Na Ayudhaya

Co-Founder
KAMBIS
Thai EU-GACP cultivation; Cost efficiency in a competitive market; AI as a cultivation advantage; Value-added cannabis product

Jesus Diaz

Head of Cultivation
Austranna
Cultivation scale-up and post-harvest planning; Yield optimisation and operational efficiency; Capacity modelling, QA handoffs, and commercial cultivation readiness.

Shabnam Sarshar

Pharmaceutical Scientist & Founder
The Recalibration
Bridging herbal tradition with cannabinoid science: Cannabis therapeutics for women’s health; Hormonal wellness and phytochemistry.

Rob Bruun

CEO & Co-Founder
Evergreen Medica
From Canadian scale-up to Thailand’s export market: Genotype and phenotype selection; GACP certification; Facility design; Elevating farm standards across Asia

Sandra De Lange

COO
Entourage Effect
From the cannabis farm startup to access — connecting suppliers, prescribers, patients, and pharmacies through technology.

Michael Abdo

Commercial Unit Leader – Microbiology, Infectious Diseases, Public Health Surveillance, Agrigenomics (AMEA)
Illumina
Genomics in One Health; microbiology; infectious diseases; agrigenomics; technology adoption; next-gen sequencing; AI in agriculture.

Paul Naske

CEO | Kaiwhakahaere
Rua Bioscience
GMP Manufacturing and Cultivation; Regulatory Compliance; New Zealand Medicinal Cannabis Market; Risk Management; Public Company Leadership

Laura Ramos

Editor-in-Chief
CannaReporter®
Award-winning cannabis journalist and editor; Portugal/EU market coverage; policy and industry insight; storytelling that connects regulators, operators, and patients.

Marika Graham-Woods

CEO | Chairman
Cannabis Trades Association (CTA)
UK medical cannabis market developments; Trade and policy; Global business opportunities in cannabis and CBD.

Matthias Bakker

Director
Blom Medical
A South African family-run GMP cannabis greenhouse: Climate control systems for challenging environments; Clean room design best practices; Navigating international compliance; Market development

Esias Meyer

Founder
JoziGrow
South African indoor cannabis cultivation; Sustainable production & renewable energy; Data, automation & operational efficiency

Kohei Yamada

Founder | CEO
KISEKI GROUP CORP
Japan’s first vertically integrated medicinal cannabis company. From Asia to Western markets: building trust through pharmaceutical-grade quality using plant-factory tech, SOP/QA systems, and proprietary genetics.

Giuseppe Plebani

Physician & Cannabinoid Medicine Specialist Private Practice, Ticino, Switzerland 
One of Switzerland’s leading medical cannabis prescribers: Individualized CBD and THC titration strategies; Real-world clinical outcomes in complex patients; Prescribing within Europe’s regulated frameworks

More speakers to be announced soon..

Interested in joining our speaker lineup?

Exhibit or Sponsor

Showcase your brand to APAC’s medicinal cannabis industry.